Details for Patent: 8,242,270

Title:	Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
Abstract:	The invention relates to processes for preparing compounds having the formula, ##STR00001## and crystalline forms thereof, wherein Ar is aryl or heteroaryl, L is an optional alkylene linker, and R.sub.2, R.sub.3, R.sub.4, and R.sub.5, are as defined in the specification herein, which compounds are useful as kinase inhibitors, in particular, inhibitors of protein tyrosine kinase and p38 kinase.
Inventor(s):	Lajeunesse; Jean (Candiac, CA), DiMarco; John D. (East Brunswick, NJ), Galella; Michael (Kendall Park, NJ), Chidambaram; Ramakrishnan (Santa Clara, CA)
Assignee:	Bristol-Myers Squibb Company (Princeton, NJ)
Filing Date:	Dec 23, 2008
Application Number:	12/342,141
Claims:	1. Crystalline butanol solvate of the compound of formula (IV) ##STR00062## 2. The compound of claim 1, characterized by unit cell parameters approximately equal to the following: Cell dimensions: a(.ANG.)=22.8102(6); b(.ANG.)=8.4691(3); c(.ANG.)=15.1436(5); .beta.=95.794(2); Volume=2910.5(2) .ANG..sup.3 Space group P2.sub.1/a Molecules/unit cell: 4 Density (calculated) (g/cm.sup.3): 1.283. 3. Crystalline ethanol solvate of the compound of formula (IV) ##STR00063## 4. The compound of claim 3, having unit cell parameters (at about -40.degree. C.) approximately equal to the following: a(.ANG.)=22.076(1); b(.ANG.)=8.9612(2); c(.ANG.)=16.8764(3); .beta.=114.783(1); Volume=3031.1(1) (.ANG..sup.3); Space group P2.sub.1/a Molecules/unit cell 4. 5. The compound of claim 3, which is characterized by an x-ray powder diffraction pattern (CuK.alpha. .lamda.=1.5418 .ANG. at a temperature of about 23.degree. C.) comprising four or more 2.theta. values selected from the group consisting of: 5.8.+-.0.2, 11.3.+-.0.2, 15.8.+-.0.2, 17.2.+-.0.2, 19.5.+-.0.2, 24.1.+-.0.2, 25.3.+-.0.2, and 26.2.+-.0.2. 6. Crystalline compound of formula (IV) ##STR00064## having unit cell parameters approximately equal to the following: a(.ANG.)=22.957(1); b(.ANG.)=8.5830(5); c(.ANG.)=13.803(3); .beta.=112.039(6); Volumer=2521.0(5) (.ANG..sup.3); Space group P2.sub.1/a Molecules/unit cell 4. 7. Crystalline compound of formula (IV) ##STR00065## which is characterized by an x-ray powder diffraction pattern (CuK.alpha. .lamda.=1.5418 .ANG. at a temperature of about 23.degree. C.) comprising four or more 2.theta. values selected from the group consisting of: 6.8.+-.0.2, 11.1.+-.0.2, 12.3.+-.0.2, 13.2.+-.0.2, 13.7.+-.0.2, 16.7.+-.0.2, 21.0.+-.0.2, 24.3.+-.0.2, and 24.8.+-.0.2. 8. Crystalline compound of formula (IV) ##STR00066## having unit cell parameters approximately equal to the following: a(.ANG.)=13.4916; b(.ANG.)=9.3992(2); c(.ANG.)=38.817(1); Volume=4922.4(3) (.ANG..sup.3); Space group Pbca. 9. Crystalline compound of formula (IV) ##STR00067## which is characterized by an x-ray powder diffraction pattern (CuK.alpha. .lamda.=1.5418 .ANG. at a temperature of about 23.degree. C.) comprising four or more 2.theta. values selected from the group consisting of: 8.0.+-.0.2, 9.7.+-.0.2, 11.2.+-.0.2, 13.3.+-.0.2, 17.5.+-.0.2, 18.9.+-.0.2, 21.0.+-.0.2, 22.0.+-.0.2. 10. The compound of claim 3, having unit cell parameters (at about -10.degree. C.) approximately equal to the following: a(.ANG.)=22.03(2); b(.ANG.)=9.20(1); c(.ANG.)=12.31(1); .beta.=93.49(6); Volume=2491(4) (.ANG..sup.3); Space group P2.sub.1/a Molecules/unit cell 4. 11. The compound of claim 3, which is characterized by an x-ray powder diffraction pattern (CuK.alpha. .lamda.=1.5418 .ANG. at a temperature of about 23.degree. C.) comprising four or more 2.theta. values selected from the group consisting of: 7.20.+-.0.2, 12.01.+-.0.2, 12.81.+-.0.2, 18.06.+-.0.2, 19.30.+-.0.2, and 25.24.+-.0.2.